"Das Klinikum Lippe ist eines der größten kommunalen Krankenhäuser in Deutschland und Teil des Universitätsklinikums OWL der Universität Bielefeld. Mit unseren Kliniken und Zentren an den Standorten Detmold, Lemgo und Bad Salzuflen halten wir nahezu jede Fachrichtung vor. Rund um die Uhr stellen wir die Gesundheitsversorgung der Bevölkerung in Ostwestfalen-Lippe und darüber hinaus sicher."

During the past decade, Klinikum Lippe - Lemgo conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 2 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Lippe - Lemgo" #1 sponsor was "German CLL Study Group" with 9 trials, followed by "University of Ulm" with 7 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials sponsored, "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 4 trials sponsored and "Biotronik SE & Co. KG" with 4 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Lippe - Lemgo" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Cancer Trials Ireland" with 2 trials as a collaborator, "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Guidant Corporation" with 2 trials as a collaborator and "Hoffmann-La Roche" with 2 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Lippe - Lemgo" are "Chronic Lymphocytic Leukemia" (7 trials), "Acute Myeloid Leukemia" (5 trials), "Leukemia" (5 trials), "Acute Myeloid Leukemia (AML)" (4 trials) and "Heart Failure" (4 trials). Many other conditions were trialed in "Klinikum Lippe - Lemgo" in a lesser frequency.

Most popular intervention types in "Klinikum Lippe - Lemgo" are "Drug" (32 trials), "Biological" (15 trials), "Device" (11 trials), "Radiation" (9 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (9 trials), "radiation therapy" (9 trials), "doxorubicin hydrochloride" (8 trials), "vincristine sulfate" (8 trials) and "filgrastim" (6 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Lippe - Lemgo" are 52 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Lippe - Lemgo". undefined are not yet recruiting, 13 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Klinikum Lippe - Lemgo, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Lippe - Lemgo, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".